chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No taste; no smell; COVID-19; low grade fever; chills; headache; coughing; A spontaneous report was received from a Healthcare professional, concerning a female patient of age 60 , who received Moderna's COVID-19 vaccine and experienced cough/coughing, pyrexia/low grade fever, chills, headache, ageusia/no taste, anosmia/no smell, COVID-19.  The patient is getting active radiation therapy. Concomitant product use was not provided by the reporter.  On 08-Jan-2021, prior to the onset of events, the patient received her first of two planned doses of mRNA-1273 (027L20A) via intramuscular route on her right deltoid  for COVID-19 infection prophylaxis.   On 08-Jan-2021, after first dose of vaccine, the patient experienced some common symptoms such as coughing. Next day, that is 09-Jan-2021 she ran a low grade fever, chills and a headache.  She thought these were side effects from the Moderna COVID-19 vaccine. She took Tylenol for the headache which helped it go away. The next day 10-Jan-2021 someone in the office said that she is around a lot tested positive for COVID so she went to get a test and came up positive. Right now she does not have a taste or smell and she is coughing a bit but over all she feels fine.   Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the event, coughing, no taste, no smell was considered to be not recovered/ not resolved. The outcome of the event, low grade fever, chills and headache was considered to be recovered/ resolved. The outcome of the event COVID-19 positive was considered to be unknown at the time of this report.  She took a test and tested positive for COVID. She took Tylenol for the headache which helped it go away.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; patient received vaccine past its 30 days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2022 at 12:41 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Feb-2022 at 12:41 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  The treatment information was unknown.
cold sensation on my legs; shivers, feeling cold; rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee; rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee; rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee; fast heart beat 1st hour after vaccine; headache; This spontaneous case was reported by a consumer and describes the occurrence of MILIARIA (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), RASH MACULAR (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), HEART RATE INCREASED (fast heart beat 1st hour after vaccine), LIMB DISCOMFORT (cold sensation on my legs) and CHILLS (shivers, feeling cold) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced HEART RATE INCREASED (fast heart beat 1st hour after vaccine) and HEADACHE (headache). On 05-Feb-2021, the patient experienced MILIARIA (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), RASH MACULAR (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), CHILLS (shivers, feeling cold) and RASH (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee). On an unknown date, the patient experienced LIMB DISCOMFORT (cold sensation on my legs). At the time of the report, MILIARIA (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), RASH MACULAR (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), HEART RATE INCREASED (fast heart beat 1st hour after vaccine), LIMB DISCOMFORT (cold sensation on my legs), CHILLS (shivers, feeling cold), RASH (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were not provided No treatment medications were not provided   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Followup received on 07-MAY-2021 and contains e-mail details.
Patient was found unresponsive at 8 am on 2/12; patient was deceased
Broke out in hives on arms and legs. Saw PCP and given Z-pack for 6 days. After finishing z-pack hives came right back. Went the ER after hives have gotten worse and went to my face. Received IV Steroids and left with a prescription for 5 days. Once done hives came back after a few days. Saw a dermatologist and was given two steriod creams. Hives became worse and started to hurt and not able to walk for a few days. Finally saw an allergist and they checked blood work and place me on daily medication. Months later and I'm still dealing with hives.
pt recvd 3 doses of Engerix-B & exp a neg titer result p/3rd dose;
Student RN inadvertently administered Hep A vaccine. Hep A series had already been completed, making this his 3rd dose. Parent notified of mistake.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with improperly stored (Oka-Merck) PROQUAD (strength, route, lot number and expiration date not reported). No adverse effects reported. This is one of two reports received from the same reported (1409USA005622). Additional information has been requested.
Swollen , pain full lymph nodes in right armpit. Also some infection like red streaking  moving distally down arm.
This spontaneous report as received from a physician regarding a male patient of unknown age. Medical history and concurrent conditions were not reported. On 10-JUN-2015, the patient received improperly stored PROQUAD (Merck) (lot# K025765, expiry date: 08-JUN-2016, dosing details were not specified) which was stored at 23 Fahrenheit for 27:00 hours. There was no concomitant medication reported. No adverse effects was reported and no product quality complain involved. This is one of several reports received from the same reporter. Additional information has been requested.
patient began having irregular and heavy menstrual bleeding for approximately 30 days following vaccination. Also broke out into a rash consistent with pityriasis rosea.
Patient received 18 month Immunizations developed fever became listless and unresponsive eyes rolled in back of head was taken to ER.
nosebleed lasting about 15 minutes with postnasal blood drip in back of throat. mild headache.
rash at injection site looks like red burn mark; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at injection site looks like red burn mark) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE RASH (rash at injection site looks like red burn mark). At the time of the report, VACCINATION SITE RASH (rash at injection site looks like red burn mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information included hot and cold treatment and she went to doctor and was given antibiotics.
fever; extreme fatigue; This is a spontaneous report from a contactable consumer (patient). A 52-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: ER8735), via an unspecified route of administration in left arm on 07May2021 at 12:15 PM (at the age of 52-year-old) as first dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient was allergic to Bactrim. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unspecified date in May2021, the patient experienced extreme fatigue and fever for 3 days. The outcome of the events was recovered on an unspecified date in May2021.
pt immediately complained of arm pain the day of vaccination and asked to be sent home. He has remained off work for two weeks. Today he was required to return to work and came to pharmacy telling me he could not move his arm and telling me he could not remain at work. I do not have any say over this and told him he should see a physician.
Day of receiving vax, pt developed redness at injection site 1 cm in diameter. Subsequently pt recovered.
Patient claiming of not being able to lift arms. She is taking Ibuprofen to help reduce discomfort. Husband got the same vaccinations and experiencing no issues. Primary physician notified.
Information has been received from a caller concerning an approximately 30 day old (reported as one month old) male who in approximately October 2010 (reported as "about a month ago") was vaccinated IM with the first 0.5ml dose of VAQTA instead of hepatitis B virus vaccine by accident. There had been no side effects experienced by the patient. It was reported that therapy with VAQTA was discontinued after the first dose. It was unknown if the patient sought medical attention. No further information is available.
severe local react, pos edema, pos tender deltoid; swelling from shoulder to elbow;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 35-year-old male patient received BNT162b2 (BNT162B2), on 14Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 34 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Overweight" (unspecified if ongoing); "Known allergies: penicillin" (unspecified if ongoing). There were no concomitant medications in 2 weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". Rebound covid on 18Jun2022, 4 days after completion of Paxlovid. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid, treatment start date=10Jun2022, treatment stop date=14Jun2022, administrator route=Oral.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the known safety profile and Limited information in the case report a casual association between events and suspect drug BNT162B2 cannot be excluded.
Three days after receiving my first Pfizer vaccine I began experiencing twitching and muscle spams all over by body. They spasms range from large jerking of my neck, head, spine, and legs, to small consist contractions and fluttering twitches all throughout my body. I am also experiencing rapid heart beats and massive amounts of anxiety as well as painful electric like shocks going through my feet and legs.
Info has been received from a medical assistant concerning 2 children patients who were vaccinated with a dose of Haemophilus B conjugate vaccine (+) hepatitis B  vaccine recombinant (yeast) (lot #643661/0723M). Subsequently the patients developed marked swelling, redness and warmth at the injection site. The patients still had a hard lump at the site one month later. Unspecified medical attention was sought. The reporter expressed a concern regarding the lot number 643661/0723M. The records of testing prior to release of this lot have been checked by GMP Compliance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Follow up info has been received from a medical assistant concerning a 12-month-old female pt with no known allergies and no past medical history who on 09/16/2002 was vaccinated IM in the right thigh with a 3rd dose of Haemophilus B conjugate vaccine (+) hepatitis B vaccine recombinant (yeast) (Lot #643661/0723M). Concomitant therapy included SQ in the left thigh a 1st dose of measles-mumps-rubella vaccine (MMR II) (Lot #642695/0490M). There was no illness at the time of vaccination. On 09/17/2002 the pt developed marked a hard lump at the injection site with swelling, redness, and warmth. The injection site area was described as being the size of a fifty cent piece. The pt was also noted to be fussy with a temperature and decreased appetite. Medical attention was sought and a complete blood count was obtained but the results were not reported. Subsequently, on 09/21/2002, the pt recovered, however it was reported that the "site is still hard". No further info is expected.Follow Up: The records of testing prior to release of this lot have been checked by GMP Compliance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and REsearch was released. No further information is available. The reporter indicated that other pts experienced adverse evetns WAES0211USA02173 AND WAES0212USA01740. No further information is expected.
Numbness on the left side of the face. Tingling in her fingers when she got the shot On the left side of her face had numbness
This spontaneous report as received from a physician via an unspecified reporter, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 23-APR-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 Single dose 0.5mLVls 10SDV" and lot number J011998 with expiration date of 12-FEB-2015 (route of administration was unknown), which was stored at -6.66 Celsius Degrees for 528 hours. The type of excursion was refrigerator and the vaccine status in excursion. No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
This spontaneous report was received from a nurse refers to a 4 months old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 30-AUG-2017, the patient was vaccinated with improperly stored ROTATEQ (dosing details were not reported) (lot # M044397, expiry date: 20-JUN-2018) orally for prophylaxis (incorrect product storage). No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments:  US-009507513-1709USA007014: US-009507513-1709USA007011: US-009507513-1709USA007012: US-009507513-1709USA007013: US-009507513-1709USA000054:
Pfizer 3/16/21, 4/6/21. Positive on 8/1/22
PT HAD A SYNCOPLE EPISODE IN HIS CAR WHILE IN OBSERVATION. -12 LEAD. NEGATIVE -BS CHECK -SKINS COLOR CHANGE. COOL, PALE, DRY  PT AMA. PT WIFE DRIVING PT HOME.  MODERNA COVID19 EUA POD VACCINE VACCINE ADVERSE REACTION.
Unable to get my blood pressure undercontrol. Increase food sensitivity; Triggers Unknown; Causing severe bowel movement (12 in a 10 hr period); Unable to eat; Happens mostly at the end of the day and through the night so I have had 3 nights of not sleeping; It seems like it is getting worse.
Patient reported scratchy throat in the evening following vaccination. By morning, swelling of face and eyelids and wheezing were occurring.
Approximately 10 minutes after the shot, while still in the doctors office, patient experienced a seizure, incontinence, headache, temporary peripheral vision loss in right eye, vomiting, dizziness.  Required emergency room visit via ambulance.  Received anti-nausea drugs via IV to end vomiting.  Released from the hospital later that night.
Hives startling on day 12 post vaccine. Come and go on different parts of body - trunk, chest, wrist, legs, neck, etc. Currently on day  16 (5 days of hives), per Dr upping dosage of Zyrtec and Benadryl.
mom reported that had welts on legs that spread over body on 14SEP92; face was puffy; welts were red & warm to touch; didn't take to hosp or MD was gone on 3rd day;
2/04/2021 Experienced stabbing R peri-orbital pain on airline flight.  Pain persisted as "sinus type pain" to mandible.  12/10/2021- Seen in the ER for persistent/atypical pain and CT for  r/o head bleed d/t Eliquis use X 9months for prior DVT/PE.   Hospitalized until 12/12/2021 with diagnosis of Left Cerebral Venous Sinus thrombosis (CVST) and new right calf DVT.       Discharged after symptom management and observation on Warfarin with Lovenox to bridge to INR of 2.0 to 3.0. Outcome:  uncertain.  On short term disability d/t persistent headaches, photopobia, and sound sensitivity.
Pt. presented to pharmacy 1 week after injection asking about bruising at injection site. Discovered the bruising and phoned his physician. Nurse stated if pt. experiencing pain or it was bothering to come in to be seen. Pt stated would wait to be seen only if gets worse.
urinating problems, during the night I can barely move, then I get up to go to the bathroom by the time i get there it's leaked out/It's painful; i get the urge to go to bathroom. It's painful, its not improving; I loss my sense of smell; can barely move; This is a spontaneous report from a contactable consumer (patient). A 91-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 06Mar2021 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. As per reporter, 1-2 days after getting the vaccine, started having "urinating problems, during the night I can barely move, then I get up to go to the bathroom by the time I get there it's leaked out enough to get my pajamas wet and then when I go to the toilet nothing comes out. This happens 5-6x per night it seems if I move, I get the urge to go to bathroom. It's painful, it's not improving. I loss my sense of smell, my wife thinks the urine smells terrible." Is this normal? He then added before getting the vaccine "had a blood test and urine test and the to doctor said I had a slight leak on the kidney". The patient underwent lab tests and procedures which included blood test: unknown results and urine analysis: unknown results on an unspecified date. The outcome of the events was unknown.  Information on Lot/Batch has been requested.
About 5 hours after the shot I developed sore arm, headache, fatigue, muscle aches, small red spot at injection site, chest pain. Everything but the chest pain went away within 48 hours. Shortness of breath and chest pain continued, shortness of breath was mostly only noticeable with excess movement. As the days went on it got worse. I saw my doctor on day 8, she said I had inflammation in my chest. I was told to take 800mg of ibuprofen every 8 hours for 2 weeks. After the first dose of ibuprofen I got stomach cramps so I started taking 600mg after that. On Day 8 in the evening I noticed a large red spot at my injection site. It was warm to the touch and slightly itchy but no pain. It has been slowly fading since.  I am now at Day 10 after the vaccine and My chest pains and shortness of breath are worse, ibuprofen do not seem to be helping.  I now get pains in my back between my shoulder blades.
Chills and shakes.  Could not stop shaking for about 1 hour, even though in bed with heavy blankets. Took Ibuprofen and turned on electric blanket. Following day felt achy and fatigued and had to be in bed.
Covid19 Pfizer Gray Top was diluted with 1.8 ml of diluent in error Patient received diluted dose
injection site reaction- swelling and tenderness where injection was given, fever of 102-103, lethargy, blotchiness on leg that injection was given
the patient fainted; vomited; This spontaneous report was received from a medical assistant via a company representative and refers to a male patient of unknown age. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (dose, route and site of administration, lot# and expiration date were not reported) for prevention of human papillomavirus (HPV) related diseases. On the same day, the patient was vaccinated with other unspecified vaccines (manufacturer unknown). The patient fainted and vomited after the administrations, while he was still at the office.  The outcome of syncope and vomiting was reported as recovered, on an unknown date. The causality assessment between the events and suspect therapy was not provided.  Upon internal review, the event of syncope was considered to be medically significant.
Information has been received from a pharmacist concerning an approximately 20 year old female with no pertinent medical history who on 28-AUG-2007 was vaccinated with a first dose of Gardasil.  Concomitant therapy included hormonal contraceptives (unspecified).  On 29-AUG-2007 the patient experienced stomach upset.  Unspecified medical attention was sought.  At the time of the report, the patient was recovering.  Additional information has been requested.
Extremely tired, severe upset stomach, severe nausea, dizzy on both sets of two series hepatitis b shot